Search PubMed⌕ Search

Biomedical subjects

D Vajda

Publications and source records attributed to D Vajda.

13 recordsLinked to original sources

Surgical management of epithelial ovarian cancer at community hospitals: A population-based study.

BACKGROUND AND OBJECTIVES: Accurate surgical staging and maximal tumor reduction are the basic management principles of epithelial ovarian cancer (EOC). The purpose of our study is to report on staging practices and the primary surgery of EOC in a region that has no tertiary oncological referral center and no surgical gynecological oncologist. METHODS: Between 1 January 1989 and 30 December 1995, the Valais Cancer Registry had registered 157 patients with ovarian cancer stage I-IV. Hospital case notes were reviewed retrospectively and patients who did not have a surgical abdominal exploration (n = 20), with borderline (n = 12) or non-epithelial tumors (n = 13), operated upon in other regions (n = 8) and without complete medical records (n = 2) were excluded. Therefore 102 patients were evaluated. RESULTS: The interventions have been performed in 7 regional hospitals and 1 private clinic by 24 obstetricians-gynecologists and 8 general surgeons. In early EOC, 9% random peritoneal biopsies and 3% retroperitoneal lymph node samplings have been performed. In advanced EOC, 40% of patients had total abdominal hysterectomy, bilateral salpingo-oophorectomy and omentectomy and 42% had cytoreductive surgery with a residual tumor of </=2 cm. CONCLUSIONS: The present study is a population-based study over a 7-year period within a region that has only community hospitals. Patients with early EOC had incomplete staging and patients with advanced EOC an insufficient rate of radical surgery. Women with a suspicion of ovarian cancer should be referred to centers with experienced tumor surgeons.

Adenocarcinoma, Mucinous↗

[15 years CA-125 antigen: usefulness and limits. Apropos of 3 clinical cases].

Fifteen years ago, the first clinical assay of the serum tumour marker CA 125 was introduced as a commercial kit. This test is currently the most widely used tumour marker in gynaecologic oncology. Studies have shown that the CA 125 is a valuable tool in the follow-up management of ovarian cancer. As a teaching exercise we present the analysis of three clinical cases, in which CA 125 was determined. Two of these patients did not have an ovarian cancer. It appears that this tumour marker very often is not only used in the follow-up of ovarian cancer, but also as a screening test and as a diagnostic tool. This inappropriate use (due to the lack of specificity and therefore many false positive results) can be avoided by considering it's limits.

Adult↗

[Pelvic hemangiopericytoma in pregnancy. Report of a case].

We report a case of pelvic retroperitoneal hemangiopericytoma (HPC) discovered early during pregnancy. Preoperative diagnosis was obtained by a transvaginal biopsy. Treatment consisted of therapeutic abortion, excision surgery and radiotherapy. In the follow-up examination 32 months after operation, no evidence of tumor recurrence was found. This is the second reported case of HPC complicating pregnancy.

Adult↗

[Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)].

BACKGROUND: Ovarian cancer is most frequently discovered at an advanced stage. The absence of symptoms in the early stages is thought to be the main reason for this late discovery. We tried to determine whether there are any specific signs or symptoms for early or late stages. METHODS: From 1989 to 1995, the Cantonal Cancer Registry recorded 124 patients with ovarian cancer; 119 (96%) cases were evaluated. We defined signs and symptoms which led to the diagnosis, their histopathological properties and the medical specialty of the physician first consulted. The data were then analyzed for early stages (IA to IB) (n = 27) and advanced stages (IC to IV) (n = 92). RESULTS: In the early as well as late stages, the most common symptoms were abdominal pain (76%) and gastrointestinal problems (45%). Bladder and gynecological symptoms were rare (25% and 7% respectively). In the early stages, however, the ovarian tumor was larger (median size 14 vs 11 cm), there were more well differentiated tumors (48% G1 vs 25%) and the age was lower (median age 55 vs 66 years). The physician first consulted was a general practitioner in 2/3 (68%) of the cases and a gynecologist in 17%. CONCLUSIONS: There are no specific ovarian carcinoma symptoms either in the early or in the late stages. The histology showed that tumors in the early stages were less aggressive and usually occurred in younger patients. The general practitioner was most often the first physician consulted by women suffering from ovarian cancer. General practitioners, therefore, should be specialists in the diagnosis of this disease, paying particular attention to women over 40 presenting with persistent abdominal pain.

Adult↗

Amniotic fluid testosterone in prenatal sex determination.

Nonconjugated testosterone levels were measured by radioimmunoassay in samples of amniotic fluid from 60 normal pregnant women between 15 and 32 weeks of gestation. In the male fetuses, the mean +/- SEM amniotic fluid testosterone levels(328 +/- 25 pg/ml) were significantly higher (p less than 0,001) than the concentrations found in the female fetuses (121 +/- 9 pg/ml). The ranges were from 155 to 730 and from 46 to 240 pg/ml respectively, which shows an overlap area of the values between the sexes from 155 to 240 pg/ml. The results emphasize the potential interest of amniotic testosterone in the determination of fetal sex.

Amniotic Fluid↗

[Enterocystoma].

Explore the source record for details and available documents.

Adult↗